CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Net Inc. Y/Y Annual
Regencell Bioscience Holdings Limited  (NASDAQ: RGC)
 

RGC's Net Income Growth by Quarter and Year

Regencell Bioscience Holdings Limited's Net Income results by quarter and year

Download as CSV




RGC Net Income (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December -3.58 -6.06 -7.59 -1.35
3rd Quarter September 0.00 0.00 0.00 0.00
2nd Quarter June 0.00 0.00 0.00 0.00
1st Quarter March 0.00 0.00 0.00 0.00
FY   -3.58 -6.06 -7.59 -1.35

RGCs Annual Net Income
Regencell Bioscience Holdings Limited's Net Income in the fiscal year 2025 $ -3.58 millions
Regencell Bioscience Holdings Limited's Net Income in the fiscal year 2023 $ -6.06 millions
Regencell Bioscience Holdings Limited's Net Income in the fiscal year 2022 $ -7.59 millions
Regencell Bioscience Holdings Limited's Net Income in the fiscal year 2021 $ -1.35 millions
Regencell Bioscience Holdings Limited's Net Income in the fiscal year 2017 $ 112.30 millions




RGC Net Income fourth quarter 2025 Y/Y Growth Comment
Regencell Bioscience Holdings Limited in the fourth quarter 2025 recorded net loss of $ -3.58 millions.

According to the results reported in the fourth quarter 2025, Regencell Bioscience Holdings Limited achieved the best Net Income growth in Legal Cannabis industry. While Regencell Bioscience Holdings Limited' s Net Income no change of 0% ranks overall at the positon no. in the fourth quarter 2025.


RGC Net Income ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Regencell Bioscience Holdings Limited's fourth quarter 2025 Net Income $ -3.58 millions RGC's Income Statement
Regencell Bioscience Holdings Limited's fourth quarter 2024 Net Income $ -6.06 millions Quarterly RGC's Income Statement


RGC Net Income (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Compare RGC Profitability >> Back to RGC Growth rate Comparisons >>


Net Income fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Regencell Bioscience Holdings Limited's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RGC's IV. Quarter Q/Q Net Income Comment


Net Income Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RGC's IV. Quarter Q/Q Net Income Comment


Regencell Bioscience Holdings Limited's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
0
Cumulative Net Income 12 Months Ending $ -3.58 $ -6.06 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #


Cumulative Net Income growth Comment


Regencell Bioscience Holdings Limited achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Regencell Bioscience Holdings Limited achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Net Income Growth
Legal Cannabis Industry Net Income Growth Trends and Statistics
Consumer Non Cyclical Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
RGC's Net Income Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth




Companies with similar Net Income no change for the quarter ending Jun 30 2025 within Consumer Non Cyclical SectorY/Y Change %Net Income for the quarter ending Jun 30 2025


About Regencell Bioscience Holdings Limited Net Income Growth Rates (RGC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.